and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products.
5. Council Directive 93/39/EEC of 14 June 1993 amending Directives 65/65/EEC, 75/318/EEC, and 75/319/EEC in respect of medicinal products.
6. Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by law, regulation, or administrative action relating to proprietary medicinal products.
7. Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmacotoxicological, and clinical standards and protocols in respect of the testing of proprietary medicinal products.
8. Second Council Directive 75/319/EEC of 20 May 1975 on the approximation of provisions laid down by law, regulation, or administrative action relating to proprietary medicinal products.
9. Council Directive 93/41/EEC of 14 June 1993 repealing Directive 87/22/EEC on the approximation of national measures relating to the placing on the market of high technology medicinal products, particularly those derived from biotechnology.
10. Council Directive 93/40/EEC of 14 June 1993 amending Directives 81/851/EEC and 81/852/EEC on the approximation of laws of the Member States relating to veterinary medicinal products.
11. Notice to Applicants for Marketing Authorization for Medicinal Products for Human Use in the Member States of the European Community Volume IIA (in revisiondraft only available). Previous version July 1993III/3567/92.
12. Commission Regulation No. 542/95 of 10 March 1995 concerning the examination of variations to the terms of a marketing authorization falling within the scope of Council Regulation (EEC) No. 2309/93.
13. Commission Regulation No. 541/95 of 10 March 1995 concerning the examination of variations to the terms of a marketing authorization granted by a competent authority of a Member State.
14. Council Regulation (EC) No. 297/95 of 10 February 1995 on Fees Payable to the European Agency for the Evaluation of Medicinal Products.
